GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (OTCPK:CSLLY) » Definitions » Other Operating Expense

CSL (CSLLY) Other Operating Expense : $879 Mil (TTM As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is CSL Other Operating Expense?

CSL's Other Operating Expense for the six months ended in Dec. 2023 was $429 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $879 Mil.

CSL's quarterly Other Operating Expense increased from Dec. 2022 ($382 Mil) to Jun. 2023 ($450 Mil) but then declined from Jun. 2023 ($450 Mil) to Dec. 2023 ($429 Mil).

CSL's annual Other Operating Expense increased from Jun. 2021 ($495 Mil) to Jun. 2022 ($543 Mil) and increased from Jun. 2022 ($543 Mil) to Jun. 2023 ($831 Mil).


CSL Other Operating Expense Historical Data

The historical data trend for CSL's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSL Other Operating Expense Chart

CSL Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 375.40 419.90 495.30 542.50 831.00

CSL Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 264.20 278.30 381.50 449.50 429.00

CSL Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $879 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CSL Other Operating Expense Related Terms

Thank you for viewing the detailed overview of CSL's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


CSL (CSLLY) Business Description

Traded in Other Exchanges
Address
655 Elizabeth Street, Melbourne, VIC, AUS, 3000
CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world's second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include non-plasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.

CSL (CSLLY) Headlines

From GuruFocus

CSL Announces Next CEO & Managing Director

By PRNewswire PRNewswire 12-12-2022